Legal & General Group
XBI icon

Legal & General Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Legal & General Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,980
Closed -$473K – 3519
2024
Q1 		$473K Buy
+4,980
New +$462K ﹤0.01% 2450

Other funds holding XBI

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Legal & General Group's XBI Position: Q2 2024 in Review

Legal & General Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 4,980 shares — an estimated $473K sold.

Legal & General Group first reported a position in XBI in Q1 2024 and held it in 1 quarter. The position peaked at $473K in Q1 2024. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

  • Legal & General Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 4,980 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $473K.
  • Legal & General Group first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and held it in 1 quarter.
  • Legal & General Group's State Street SPDR S&P Biotech ETF position peaked at $473K in Q1 2024.
  • 761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.